|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.532
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.418
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.321
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.293
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.269
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.216
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.215
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.188
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.185
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.167
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.162
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.159
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.150
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.135
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.132
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.131
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.131
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.127
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.121
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.121
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.119
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.118
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.117
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.112
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.112
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.111
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.111
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.110
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.108
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.104
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.103
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.102
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.101
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.101
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.101
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.100
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.099
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.098
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.096
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.095
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.095
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.095
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.094
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.094
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.091
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.089
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.088
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.086
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.085
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.085
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.084
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.083
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.082
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.082
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.082
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.081
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.080
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.079
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.079
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.079
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.078
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.077
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.077
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.074
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.074
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.074
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.074
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.074
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.073
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.072
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.072
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.071
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.071
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.071
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.071
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.071
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.071
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.071
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.071
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.070
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.068
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.067
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.067
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.067
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.066
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.066
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.065
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.064
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.064
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.064
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.064
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.064
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.063
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.063
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.062
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.061
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.061
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.061
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.061
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.061
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.060
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.060
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.059
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.059
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.059
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.058
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.058
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.058
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.058
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.058
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.057
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.057
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.057
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.056
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.056
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.056
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.055
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.055
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.055
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.053
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.053
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.053
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.052
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.052
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.052
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.051
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.051
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.051
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.051
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.051
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.051
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.051
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.050
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.050
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.050
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.050
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.049
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.049
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.049
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.049
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.049
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.048
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.048
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.048
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.047
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.047
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.047
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.047
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.046
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.046
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.046
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.046
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.046
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.046
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.045
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.045
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.045
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.045
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.045
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.044
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.044
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.044
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.043
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.043
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.043
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.043
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.043
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.043
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.042
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.042
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.042
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.042
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.042
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.042
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.042
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.041
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.041
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.041
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.041
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.041
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.041
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.041
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.041
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.041
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.041
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.040
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.040
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.040
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.040
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.039
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.039
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.039
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.039
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.039
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.039
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.039
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.038
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.038
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.038
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.038
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.038
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.038
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.038
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.038
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.037
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.037
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.037
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.037
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.037
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.037
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.037
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.036
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.036
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.036
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.036
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.036
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.035
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.035
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.035
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.035
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.035
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.035
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.034
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.034
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.034
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.034
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.034
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.034
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.034
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.034
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.033
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.033
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.033
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.033
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.033
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.033
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.033
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.033
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.033
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.032
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.032
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.032
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.032
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.032
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.032
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.032
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.032
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.032
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.032
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.032
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.032
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.032
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.032
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.031
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.031
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.031
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.031
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.031
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.030
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.030
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.030
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.030
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.030
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.030
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.030
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.030
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.029
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.029
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.029
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.029
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.029
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.029
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.029
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.029
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.029
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.029
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.029
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.029
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.028
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.028
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.028
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.028
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.028
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.028
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.027
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.027
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.027
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.027
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.027
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.027
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.027
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.027
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.027
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.026
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.026
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.026
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.026
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.026
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.026
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.026
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.026
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.026
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.026
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.026
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.026
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.026
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.026
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.026
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.025
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.025
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.025
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.025
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.025
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.025
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.025
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.025
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.024
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.024
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.024
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.024
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.024
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.024
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.024
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.024
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.024
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.024
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.024
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.024
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.024
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.023
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.023
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.023
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.023
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.023
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.023
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.023
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.023
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.023
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.023
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.023
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.023
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.022
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.022
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.022
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.022
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.022
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.022
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.022
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.022
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.022
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.022
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.022
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.022
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.021
|
|
|
|
negative regulation of transcription by glucose
|
GO:0045014 |
1 |
0.021
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.021
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.021
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.021
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.021
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.021
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.021
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
|
granulosa cell differentiation
|
GO:0060014 |
1 |
0.021
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.021
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.021
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.021
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.021
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.021
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.020
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.020
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.020
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.020
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.020
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.020
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.020
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.020
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.020
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.020
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.020
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.020
|
|
|
|
phosphatidylethanolamine metabolic process
|
GO:0046337 |
2 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.020
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.020
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.020
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.020
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
5 |
0.020
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.020
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.019
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.019
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.019
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.019
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.019
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.019
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.019
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.019
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.019
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.019
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.019
|
|
|
|
notochord cell development
|
GO:0060035 |
1 |
0.019
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.019
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.019
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.019
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.019
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.019
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.019
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.019
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.019
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.019
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.019
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.019
|
|
|
|
detection of glucose
|
GO:0051594 |
1 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.018
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.018
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.018
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.018
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
32 |
0.018
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.018
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.018
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.018
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.018
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.018
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.018
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.018
|
Human |
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.018
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.018
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.018
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.018
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.017
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.017
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.017
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.017
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.017
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.017
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.017
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.017
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.017
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.017
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.017
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.017
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.017
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.017
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.017
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.017
|
|
|
|
somite specification
|
GO:0001757 |
4 |
0.017
|
|
